Skip to main content
Fig. 2 | Pediatric Rheumatology

Fig. 2

From: The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource

Fig. 2

Percentage of missingness across key variables in the CLUSTER MTX and TNF datasets

MTX Methotrexate, TNF Tumour necrosis factor inhibitors, T1 Timepoint 1 (closest values to baseline; allowed -3 months to drug start), T2 Timepoint 2 (closest value to 6 months after drug start; allowed 3–12 months after drug start), JIA Juvenile idiopathic arthritis, RF Rheumatoid factor, HLA B27 Human leukocyte antigen B27, ANA Anti-nuclear antibody, CHAQ Childhood health assessment questionnaire, ESR Erythrocyte sedimentation rate, CRP C-reactive protein, VAS Visual analogue scale

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096